Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD)

Summary

This study assessed whether AFQ056 had a beneficial effect by reducing cocaine use in Cocaine Use Disorder (CUD) patients as assessed by Timeline Follow-Back cocaine self-report.

Timeline

Start

2017-12-04

Primary completion

2019-12-16

Completion

2019-12-16

Outcome

Met primary endpoint

registry analysis (superiority test); AFQ056 vs Placebo; p = 0.021; Mean Difference (Final Values) -0.087 (95% CI -0.161 to -0.013); ANCOVA NCT03242928 ↗

Drugs

Indications